Study of drugs affecting cholesterol-induced atherosclerosis in rabbits

Area of Science:

• Pharmacology
• Cardiovascular Research
• Experimental Pathology

Background:

• Atherosclerosis is a complex disease characterized by plaque buildup in arteries.
• Understanding the progression phase is crucial for developing effective treatments.
• Drug interventions are explored to mitigate cholesterol-induced atherosclerosis.

Purpose of the Study:

• To evaluate the efficacy of various drugs in treating cholesterol-induced atherosclerosis during its progression phase in rabbits.
• To identify potential therapeutic agents for managing atherosclerotic lesion development.

Main Methods:

• Rabbits were induced with cholesterol to develop atherosclerosis.
• Various drug classes were administered, including antimetabolites, surface active agents, steroid synthesis inhibitors, lysosome stabilizers, and cholesterol binders.
• Atherosclerotic lesions, serum cholesterol, and aortic cholesterol concentrations were measured.

Main Results:

• Mercaptopurine demonstrated a marked reduction in atherosclerotic lesions and cholesterol levels (serum and aorta).
• Hydroxyurea decreased aortic cholesterol and lesions but did not lower serum cholesterol.
• Sodium dodecyl sulfate and o,p'-DDD showed slight inhibition; Pyridinocarbamate had a minor preventive effect when given pre-meal.
• Nystatin, chloroquine, and acetylsalicylic acid + chlorpheniramine exhibited minimal effects.

Conclusions:

• Mercaptopurine shows significant potential in managing cholesterol-induced atherosclerosis progression.
• Most tested drugs have limited efficacy in this model, highlighting the need for targeted therapies.
• Further research into antimetabolites may yield effective treatments for atherosclerosis.